PetMed Express (PETS) | Stock Overview & Key Data
PetMed Express Performance Comparison
Stock Range
Today's Range
Low: $2.99
High: $3.13
on August 20, 2025
52 Week Range
Low: $2.81
High: $6.85
on December 9, 2024
All-Time High: $57.80 on January 22, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$62.6M
EPS
0.01
P/E Ratio (TTM)
303.00
Forward P/E
-101.00
P/B Ratio
0.65
PEG Ratio
-4.33
Div. Yield
N/A
ROE
0.36%
Beta
0.822
Debt to Equity
1.15
Financial Highlights
Profitability
Gross Margin
28.14%
Operating Margin
-0.85%
Profit Margin
0.15%
Returns and Earnings
Return on Assets (TTM)
0.93%
Return on Equity (TTM)
0.36%
EBITDA
$8.2M
Net Income (TTM)
$357.0K
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$11.68
Quarterly Revenue Growth (YoY)
-18.90%
Quarterly Earnings Growth (YoY)
-18.88%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PetMed Express PETS | 62.59M Micro-cap | -2.80% | -8.50% | -22.39% | -29.25% | -32.76% | 0.65% | -84.56% | -91.00% |
| Walgreens Boots WBA | 10.46B Large-cap | 2.61% | 5.90% | 8.64% | 16.08% | 32.75% | 18.45% | -66.11% | -68.52% |
| High Tide HITI | 248.48M Micro-cap | 25.20% | 28.87% | 31.06% | 19.38% | -7.23% | 57.14% | 115.38% | -2.22% |
| Wellgistics Health WGRX | 56.79M Micro-cap | 17.14% | -30.51% | -69.17% | -78.48% | -78.48% | -78.48% | -78.48% | -78.48% |
| Scienture Holdings SCNX | 19.52M Micro-cap | -51.80% | -50.00% | 16.30% | -60.81% | -82.17% | -86.47% | -94.20% | -98.76% |
| Hong Kong Pharma HKPD | 11.55M Micro-cap | -8.18% | -25.74% | -4.72% | -42.94% | -64.18% | -63.27% | -63.27% | -63.27% |
Ownership & Short Interest
Insider Ownership
30.82%
Institutional Ownership
38.00%
Shares Short
2M
Short Ratio
10.67
Short % of Shares Outstanding
8.89%
Average 10-Day Volume
147K
Average 90-Day Volume
166K
PetMed Express Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in PetMed Express would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PETS's 52-week high and low?
- In the last 52 weeks, PetMed Express reached a high of $6.85 (on December 9, 2024) and a low of $2.81 (on N/A).
- What is the market cap and P/E ratio for PETS?
- Curious about PetMed Express's size and valuation? Its market capitalization stands at 62.59M. When it comes to valuation, the P/E ratio (trailing twelve months) is 303.00, and the forward P/E (looking ahead) is -101.00.
- Does PETS pay dividends? If so, what's the yield?
- As for dividends, PetMed Express isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are PetMed Express's main competitors or similar companies to consider before investing?
When looking at PetMed Express, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Walgreens Boots
WBA10.46B Healthcare Pharmaceutical Retailers 18.45% -66.11% High Tide
HITI248.48M Healthcare Pharmaceutical Retailers 57.14% 115.38% Wellgistics Health
WGRX56.79M Healthcare Pharmaceutical Retailers -78.48% -78.48% Scienture Holdings
SCNX19.52M Healthcare Pharmaceutical Retailers -86.47% -94.20% Hong Kong Pharma
HKPD11.55M Healthcare Pharmaceutical Retailers -63.27% -63.27% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for PetMed Express Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of PetMed Express's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.36%, the Debt to Equity ratio from the most recent quarter is 1.15, and its Gross Profit Margin stands at 28.14%.
- What is the recent revenue and earnings growth for PETS?
- Looking at PetMed Express's growth, its revenue over the trailing twelve months (TTM) was $247M. Compared to the same quarter last year (YoY), quarterly revenue grew by -18.90%, and quarterly earnings saw a YoY growth of -18.88%.
- How much of PETS stock is held by insiders and institutions?
- Wondering who owns PetMed Express stock? Company insiders (like executives and directors) hold about 30.82% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 38.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.